Neural Biomarkers of Electroconvulsive Therapy Response

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

July 1, 2025

Conditions
Electroconvulsive Therapy Treated Patients
Interventions
DIAGNOSTIC_TEST

clinical and neuropsychological testing

Patients are monitored with Brief Psychiatric Rating Scale (BPRS) weekly and structural and functional MRI and MATRICS battery before and at the end of the course of the study

Trial Locations (1)

11004

RECRUITING

The Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Northwell Health

OTHER

NCT04763655 - Neural Biomarkers of Electroconvulsive Therapy Response | Biotech Hunter | Biotech Hunter